TherOptix is an early-stage biopharmaceutical company focused on optimizing therapeutic benefit and clinical outcomes by delivering controlled, modifiable drug concentrations through contact lens to the front and/or back of the eye. The innovative, non-invasive technology platform enables clinically impactful therapeutic delivery.